earnings
saveSanofi earnings
community read0 votes
Anticipated earnings call for Sanofi ($SNY).
view source ↗Data sources
Found something off?
related news · 8
- endpointsSanofi may seek higher European drug prices, not withhold launches, under Trump deal
- biospaceRegeneron achieves ‘clean sweep’ in Q3 with myriad pipeline catalysts on deck
- biospaceSanofi targets late-phase and commercial M&A to offset looming Dupixent decline
- biospace‘We need to do better,’ Alnylam CEO admits, as uncertainty looms over transthyretin franchise
- endpointsSanofi has no plans for 'major restructuring' as Dupixent's patent cliff looms
- biospaceNew biotech Setara forms with $90M to take on Jazz’s bonus rare disease programs
- fiercebiotechSanofi considering ‘moonshot’ treatments as M&A targets to survive Dupixent patent cliff
- biospaceDren Bio lands $350M to push rare blood cancer therapy toward market
🐶 often sniffed alongside
top 8- tagApproval433 co-mentions · 217 sources
- company$SNYNFSanofi234 co-mentions · 225 sources
- drugRIFADIN233 co-mentions · 117 sources
- tagSmall Molecule168 co-mentions · 168 sources
- drugrifampin117 co-mentions · 117 sources
- drugRIFATER50 co-mentions · 25 sources
- drugPRIMAQUINE36 co-mentions · 18 sources
- drugrifapentine34 co-mentions · 17 sources
comments(0)
5-min edit window · permanent after that